Median time to deterioration in FACT-P total score was 113 months ( 95 % CI 111-139 ) in the enzalutamide group and 56 months ( 55-56 ) in the placebo groups ( hazard ratio [ HR ] 062 [ 95 % CI 054-072 ] ; p < 00001 ) .